title: Significant interaction of tacrolimus with ritonavir during allogeneic hematopoietic SCT in an HIV-infected patient.
authors: M
authors: M
authors: Miceli
authors: S
authors: S
authors: Cronin
authors: L
authors: L
authors: Ayash
authors: G
authors: G
authors: Alangaden
authors: P H
authors: PH
authors: Chandrasekar
mesh_terms: D004336:Drug Antagonism; D015658:HIV Infections / Q000150:complications / Q000628:therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D016411:Lymphoma, T-Cell, Peripheral / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D019438:Ritonavir / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D016559:Tacrolimus / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D014184:Transplantation, Homologous
chemical_list: D017320:HIV Protease Inhibitors; D007166:Immunosuppressive Agents; D019438:Ritonavir; D016559:Tacrolimus